Ventyx Biosciences
Why Robinhood?
You can watch VTYX and buy or sell other stocks, ETFs, and their options commission-free!About VTYX
Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions.
VTYX Key Statistics
Stock Snapshot
As of today, Ventyx Biosciences(VTYX) shares are valued at $14.00. The company's market cap stands at 998.72M, with a P/E ratio of -9.34.
On 2026-05-13, Ventyx Biosciences(VTYX) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 732.43K.
Over the past 52 weeks, Ventyx Biosciences(VTYX) stock has traded between a high of $25.00 and a low of $0.78.
Over the past 52 weeks, Ventyx Biosciences(VTYX) stock has traded between a high of $25.00 and a low of $0.78.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.